ArticleVaccines2024

Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d'Aosta Region, Italy, in the 2023-2024 Epidemic Season.

Alessandra Consolati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.